MKI67 and neoplasm: Our scRNA-seq data for intra-tumoral TCR-T cells revealed the age-related decrease in the frequency of Mki67-expressing Tpex-like cells (cluster 0), which can persist in tumors and sustain effective anti-tumor CD8 T cell responses more effectively than Tex cells (46, 47).